Femme Homme | 18 ans et plus
- | Pays :
- France
- | Organes :
- Utérus
- | Spécialités :
- Thérapies Ciblées
Extrait
A phase II, open-label, randomized, multicenter trial of pazopanib (GW786034) in combination with lapatinib (GW572016) compared to pazopanib monotherapy and lapatinib monotherapy in subjects with Figo stage IVB or recurrent or persistent cervical cancer with zero or one prior chemotherapy regimen for advanced/recurrent disease.
Extrait Scientifique
en cours d'intégration;